PacBio to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
Rhea-AI Summary
PacBio (NASDAQ: PACB) will report fourth quarter and full year 2025 financial results on Thursday, February 12, 2026. A quarterly conference call and webcast will be held at 5:00 PM Eastern Time (2:00 PM Pacific) and will be accessible via PacBio's investor website.
Investors can listen live via the webcast or by phone: toll-free 1-888-349-0136 or international 1-412-317-0459. A replay will be available on the investor site after the call.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
PACB is down 2.33% while peers show mixed moves: RXST up 0.21%, SRDX up 0.26%, SENS down 2.48%, CTKB down 0.95%, and DCTH flat, indicating stock-specific trading rather than a unified sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 12 | Strategic collaboration | Positive | +3.6% | Collaboration to apply HiFi long-read sequencing to ultra-rare genetic diseases. |
| Jan 12 | Technology adoption | Positive | +3.6% | HiFi whole-genome sequencing adopted as first-line approach for SUDC study. |
| Jan 12 | Preliminary revenue | Positive | +3.6% | Preliminary Q4 and 2025 revenue update with growth and cash balance detail. |
| Jan 08 | Technology update | Positive | -4.2% | Introduction of CiFi long-read 3C method enabling chromosome-scale assemblies. |
| Dec 30 | Conference appearance | Neutral | +1.2% | Announcement of presentation at the 44th Annual J.P. Morgan Healthcare Conference. |
Recent fundamentally positive updates, especially preliminary 2025 revenue and strategic collaborations, mostly saw aligned positive price reactions, with one notable divergence on a technical/technology update.
Over the past month, PACB issued several updates, including a collaboration on rare genetic disease therapies (Jan 12, 2026), adoption of HiFi sequencing for SUDC research (Jan 12, 2026), and preliminary Q4 and full-year 2025 revenue, which all saw +3.61% next-day moves. A CiFi method announcement on Jan 8, 2026 drew a -4.23% reaction despite positive technical content. A J.P. Morgan conference appearance on Dec 30, 2025 coincided with a modest +1.17% move.
Market Pulse Summary
This announcement sets February 12, 2026 at 5:00 pm ET as the key date for final fourth quarter and full year 2025 results, following earlier preliminary revenue disclosures. Investors tracking PACB’s recent collaboration, technology adoption, and preliminary revenue news may focus on how audited numbers and guidance compare with prior indications. The call also provides context for the company’s position near its $2.73 52-week high and above the $1.55 200-day moving average.
AI-generated analysis. Not financial advice.
MENLO PARK, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, February 12, 2026, at 5:00 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at https://investor.pacificbiosciences.com/.
Date: Thursday, February 12, 2026, at 5:00 pm ET (2:00 pm PT)
Listen live via internet or replay: https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Jim Gibson
ir@pacb.com
Media:
pr@pacb.com
FAQ
When will PacBio (PACB) report its Q4 and full year 2025 results?
How can I listen to the PacBio (PACB) earnings call on February 12, 2026?
What time is PacBio's (PACB) earnings call in Pacific Time?
Will PacBio (PACB) provide a replay of the February 12, 2026 call?
Where is the PacBio (PACB) webcast for the February 12, 2026 results hosted?
What topics will PacBio (PACB) cover on the February 12, 2026 conference call?
